Melanocytes as "sensory" and regulatory cells in the epidermis.

PubWeight™: 1.55‹?› | Rank: Top 4%

🔗 View Article (PMID 8264240)

Published in J Theor Biol on September 07, 1993


A Slominski1, R Paus, D Schadendorf

Author Affiliations

1: Department of Pathology, Albany Medical College, NY 12208.

Articles citing this

Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99

L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment Cell Melanoma Res (2011) 2.07

Hair follicle pigmentation. J Invest Dermatol (2005) 1.84

Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77

Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer (2009) 1.70

Basis for enhanced barrier function of pigmented skin. J Invest Dermatol (2014) 1.49

Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Hum Pathol (2011) 1.38

UV radiation and the skin. Int J Mol Sci (2013) 1.37

The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways. Arch Biochem Biophys (2014) 1.36

Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol (1994) 1.30

Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol (2006) 1.16

Neuroendocrine activity of the melanocyte. Exp Dermatol (2009) 1.12

A synthetic sandalwood odorant induces wound-healing processes in human keratinocytes via the olfactory receptor OR2AT4. J Invest Dermatol (2014) 1.08

The role of melanin pigment in melanoma. Exp Dermatol (2015) 1.03

Melanocyte receptors: clinical implications and therapeutic relevance. Dermatol Clin (2007) 1.01

On the role of skin in the regulation of local and systemic steroidogenic activities. Steroids (2015) 1.01

Aging of the hair follicle pigmentation system. Int J Trichology (2009) 1.00

Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97

Putative role of HIF transcriptional activity in melanocytes and melanoma biology. Dermatoendocrinol (2013) 0.92

Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy. FASEB J (2010) 0.91

Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women. Pain (2015) 0.85

High-resolution magic angle spinning nuclear magnetic resonance analysis of metabolic changes in melanoma cells after induction of melanogenesis. Anal Biochem (2008) 0.84

Cooling skin cancer: menthol inhibits melanoma growth. Focus on "TRPM8 activation suppresses cellular viability in human melanoma". Am J Physiol Cell Physiol (2008) 0.83

Perivascular macrophage-like melanocyte responsiveness to acoustic trauma--a salient feature of strial barrier associated hearing loss. FASEB J (2013) 0.82

Understanding the melanocyte distribution in human epidermis: an agent-based computational model approach. PLoS One (2012) 0.81

Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol (2011) 0.81

Photoprotective and antioxidant effects of Rhubarb: inhibitory action on tyrosinase and tyrosine kinase activities and TNF-α, IL-1α and α-MSH production in human melanocytes. BMC Complement Altern Med (2013) 0.80

Melanocyte stem cells as potential therapeutics in skin disorders. Expert Opin Biol Ther (2014) 0.80

Violet light down-regulates the expression of specific differentiation markers through Rhodopsin in normal human epidermal keratinocytes. PLoS One (2013) 0.79

Melanocyte pigmentation inversely correlates with MCP-1 production and angiogenesis-inducing potential. FASEB J (2014) 0.79

The Effect of MCP-1/CCR2 on the Proliferation and Senescence of Epidermal Constituent Cells in Solar Lentigo. Int J Mol Sci (2016) 0.78

The mathematics of tanning. BMC Syst Biol (2009) 0.77

5-HT1A/1B receptors as targets for optimizing pigmentary responses in C57BL/6 mouse skin to stress. PLoS One (2014) 0.77

The melanocyte photosensory system in the human skin. Springerplus (2013) 0.77

Migrating melanocyte stem cells: masters of disaster? Nat Med (2013) 0.77

Skin under the sun: when melanin pigment meets vitamin D. Endocrinology (2015) 0.76

Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management. Lab Invest (2017) 0.75

The Development of Sugar-Based Anti-Melanogenic Agents. Int J Mol Sci (2016) 0.75

Does melanin matter in the dark? Exp Dermatol (2016) 0.75

Articles by these authors

(truncated to the top 100)

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48

A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12

Sonic hedgehog signaling is essential for hair development. Curr Biol (1998) 5.58

Controls of hair follicle cycling. Physiol Rev (2001) 5.49

Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99

Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98

Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22

Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09

Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95

Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol (1993) 1.88

Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82

Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol (2001) 1.75

Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71

Lack of clinical efficacy of imatinib in metastatic melanoma. Br J Cancer (2005) 1.66

What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma. Ann Oncol (2014) 1.63

Retracted Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J (1999) 1.60

Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58

Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin. Eur J Cancer (2002) 1.51

Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48

Human mast cells produce IL-8. J Immunol (1993) 1.44

Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma. Onkologie (2004) 1.43

The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42

Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J Pathol (1999) 1.40

Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol (1998) 1.40

The 'melanocyte-keratin' mystery revisited: neither normal human epidermal nor hair follicle melanocytes express keratin 16 or keratin 6 in situ. Br J Dermatol (2009) 1.39

Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39

The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol (1999) 1.38

The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol (1999) 1.38

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer (2013) 1.38

Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol (1999) 1.37

Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol (1998) 1.37

Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34

Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp Dermatol (1998) 1.33

Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis (1999) 1.30

Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis? J Immunol (2000) 1.29

Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res (1999) 1.29

Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res (2009) 1.29

Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol (2000) 1.29

Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle. J Invest Dermatol (1994) 1.27

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma. J Immunother (2000) 1.27

Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26

Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair. FASEB J (2009) 1.25

Management of alopecia areata. BMJ (2010) 1.25

Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol (1991) 1.24

Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci U S A (2001) 1.24

The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer (1999) 1.22

E- and P-cadherin expression during murine hair follicle morphogenesis and cycling. Exp Dermatol (1999) 1.22

Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21

Retracted The IL-15R alpha chain signals through association with Syk in human B cells. J Immunol (2001) 1.20

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group. J Clin Oncol (1997) 1.20

Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol (1997) 1.20

Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18

Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18

Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun (2004) 1.18

Biomarkers in melanoma. Ann Oncol (2009) 1.17

Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol (1997) 1.17

Indications for a 'brain-hair follicle axis (BHA)': inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J (2001) 1.17

Drug-resistance in human melanoma. Int J Cancer (2001) 1.15

What causes alopecia areata? Exp Dermatol (2013) 1.14

Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis (2000) 1.14

Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survival. Br J Cancer (2002) 1.11

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma. Br J Cancer (2011) 1.10

Small molecules and targeted therapies in distant metastatic disease. Ann Oncol (2009) 1.08

Towards defining the pathogenesis of the hairless phenotype. J Invest Dermatol (1998) 1.06

Proopiomelanocortin expression in the skin during induced hair growth in mice. Experientia (1992) 1.05

Distinct patterns of NCAM expression are associated with defined stages of murine hair follicle morphogenesis and regression. J Histochem Cytochem (1998) 1.05

Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT. Int J Cancer (2001) 1.05

On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol (1993) 1.04

Human dendritic cells infected by Listeria monocytogenes: induction of maturation, requirements for phagolysosomal escape and antigen presentation capacity. Eur J Immunol (2000) 1.04

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer (2002) 1.03

Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol (2008) 1.03

Keratin 17 gene expression during the murine hair cycle. J Invest Dermatol (1997) 1.03

DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells. FEBS Lett (2001) 1.03

Dose-dependent severe cutaneous reactions to imatinib. Br J Cancer (2003) 1.03

Management of primary cicatricial alopecias: options for treatment. Br J Dermatol (2008) 1.03

Merkel cells in mouse skin: intermediate filament pattern, localization, and hair cycle-dependent density. J Invest Dermatol (1996) 1.02

Patterns of proliferation and apoptosis during murine hair follicle morphogenesis. J Invest Dermatol (2001) 1.02

Patterns of hairless (hr) gene expression in mouse hair follicle morphogenesis and cycling. Am J Pathol (2000) 1.00

Mutant laboratory mice with abnormalities in hair follicle morphogenesis, cycling, and/or structure: annotated tables. Exp Dermatol (2001) 1.00

How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia. Br J Dermatol (2009) 0.99

Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J (1998) 0.99

A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression. FASEB J (2000) 0.98

Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br J Dermatol (2005) 0.98

High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br J Dermatol (2000) 0.98

Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest (1997) 0.98

The bulge is the source of cellular renewal in the sebaceous gland of mouse skin. Arch Dermatol Res (2000) 0.98

Is our self based on reward? Self-relatedness recruits neural activity in the reward system. Neuroimage (2007) 0.97

Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7. Br J Dermatol (2009) 0.97

Hair-cycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol (2001) 0.97

Cutaneous large B-cell lymphoma of the leg masquerading as a chronic venous ulcer. Br J Dermatol (2002) 0.97

Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 act as "epitheliotrophins" in murine skin. Lab Invest (1999) 0.97

Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. Int J Cancer (2000) 0.96

Molecular basis for the rhino Yurlovo (hr(rhY)) phenotype: severe skin abnormalities and female reproductive defects associated with an insertion in the hairless gene. Exp Dermatol (1998) 0.96

The polymerase chain reaction. Method and applications in dermatopathology. Am J Dermatopathol (1993) 0.96

Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J Immunol (1998) 0.96

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis. Eur J Cancer (2004) 0.96

Substance use and sexual risk behaviour among HIV-positive men who have sex with men in specialized out-patient clinics. HIV Med (2012) 0.96

Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion. J Histochem Cytochem (1998) 0.96